Author

Michael Reedijk

Observed names: M Reedijk, M. Reedijik, M. Reedijk, MJ Reedijk

Observed institutions: Dartmouth College, Ontario Institute for Cancer Research, Mount Sinai Hospital, Mount Sinai Hospital, University Health Network, University of California, San Francisco, University of Toronto, Lunenfeld-Tanenbaum Research Institute, Great Ormond Street Hospital, Hospital for Sick Children, Women's College Hospital, Princess Margaret Cancer Centre, Mount Sinai Hospital, Mount Sinai Hospital, Princess Margaret Hospital, Campbell Family Institute for Breast Cancer Research, McMaster University

ORCID: 0000-0002-4305-723X

Observed ORCID: 0000-0002-4305-723X

OpenAlex ID: A5000884036

High-level Coexpression of JAG1 and NOTCH1 Is Observed in Human Breast Cancer and Is Associated with Poor Overall Survival

2005 · Michael Reedijk, Silvia Odorcic, et al. · Cancer Research · 783

PDF

The Steel/W transduction pathway: kit autophosphorylation and its association with a unique subset of cytoplasmic signaling proteins is induced by the Steel factor.

1991 · R Rottapel, M Reedijk, et al. · Molecular and Cellular Biology · 250

Metformin in early breast cancer: a prospective window of opportunity neoadjuvant study

2012 · Saroj Niraula, Ryan J. O. Dowling, et al. · Breast Cancer Research and Treatment · 238

Tyr721 regulates specific binding of the CSF‐1 receptor kinase insert to PI 3′‐kinase SH2 domains: a model for SH2‐mediated receptor‐target interactions.

1992 · M. Reedijk, X. Liu, et al. · The EMBO Journal · 229

PDF

High-level JAG1 mRNA and protein predict poor outcome in breast cancer

2007 · Brendan C Dickson, Anna Marie Mulligan, et al. · Modern Pathology · 221

PDF

A Multicentered, Randomized, Controlled Trial Comparing Radioguided Seed Localization to Standard Wire Localization for Nonpalpable, Invasive and in situ Breast Carcinomas

2011 · Peter J. Lovrics, Charlie H. Goldsmith, et al. · Annals of Surgical Oncology · 199

SH2 Domains of the p85α Subunit of Phosphatidylinositol 3-Kinase Regulate Binding to Growth Factor Receptors

1992 · C. Jane Mcglade, Christine Ellis, et al. · Molecular and Cellular Biology · 185

Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer

2009 · Brenda Cohen, Mamiko Shimizu, et al. · Breast Cancer Research and Treatment · 159

Interactions of Phosphatidylinositol Kinase, GTPase-Activating Protein (GAP), and GAP-Associated Proteins with the Colony-Stimulating Factor 1 Receptor

1990 · M Reedijk, X Q Liu, et al. · Molecular and Cellular Biology · 154

Notch Signaling Pathway as a Therapeutic Target in Breast Cancer

2010 · Hamed Al-Hussaini, Deepa Subramanyam, et al. · Molecular Cancer Therapeutics · 151

JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer

2007 · Michael Reedijk, Dushanthi Pinnaduwage, et al. · Breast Cancer Research and Treatment · 147

Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2

2019 · Linh T. Nguyen, Samuel D. Saibil, et al. · Cancer Immunology Immunotherapy · 143

PDF

High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer

2013 · Julia Izrailit, Hal K. Berman, et al. · Proceedings of the National Academy of Sciences · 127

PDF

Notch Shapes the Innate Immunophenotype in Breast Cancer

2017 · Qiang Shen, Brenda Cohen, et al. · Cancer Discovery · 122

Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study

2015 · Ryan JO Dowling, Saroj Niraula, et al. · Breast Cancer Research · 117

PDF

Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma

2018 · Aras Toker, Linh T. Nguyen, et al. · Clinical Cancer Research · 108

Bowel resection for intestinal endometriosis

1998 · David R. Urbach, Michael Reedijk, et al. · Diseases of the Colon & Rectum · 104

The association of insulin-elicited phosphotyrosine proteins with src homology 2 domains.

1992 · B.E. Lavan, M.R. Kuhné, et al. · Journal of Biological Chemistry · 98

A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia

2015 · Ivan Diaz-Padilla, Michelle K. Wilson, et al. · Gynecologic Oncology · 83

Notch Signaling and Breast Cancer

2012 · Michael Reedijk · Advances in experimental medicine and biology · 82

A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)

2013 · Suzanne Richter, Philippe L. Bedard, et al. · Investigational New Drugs · 80

PDF

A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)

2013 · S Sahebjam, P L Bedard, et al. · British Journal of Cancer · 75

PDF

The c-fms gene complements the mitogenic defect in mast cells derived from mutant W mice but not mi (microphthalmia) mice.

1991 · P Dubreuil, L Forrester, et al. · Proceedings of the National Academy of Sciences · 66

The unique insert of cellular and viral fms protein tyrosine kinase domains is dispensable for enzymatic and transforming activities.

1989 · G. R. Taylor, M. Reedijk, et al. · The EMBO Journal · 66

Plasminogen Activator uPA Is a Direct Transcriptional Target of the JAG1-Notch Receptor Signaling Pathway in Breast Cancer

2011 · Mamiko Shimizu, Brenda Cohen, et al. · Cancer Research · 65

Works count: 130

Citation count: 4,743

H-index: 34

I10-index: 43